Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
  • Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

PARP Inhibitors for Advanced Prostate Cancer: Validating Predictive Biomarkers.

Thumbnail
View/Open
Accepted version (88.40Kb)
Date
2019-10
ICR Author
Carreira, Suzanne
De Bono, Johann
Author
Mateo, J
Carreira, S
de Bono, JS
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/3213
DOI
https://doi.org/10.1016/j.eururo.2019.03.029
Collections
  • Cancer Therapeutics
  • Clinical Studies
Subject
Humans
Piperazines
Phthalazines
BRCA1 Protein
BRCA2 Protein
Mutation
Male
Ataxia Telangiectasia Mutated Proteins
Prostatic Neoplasms, Castration-Resistant
Biomarkers
Poly(ADP-ribose) Polymerase Inhibitors
Research team
Cancer Biomarkers
Prostate Cancer Targeted Therapy Group
Language
eng
Date accepted
2019-03-21
License start date
2019-10
Citation
European urology, 2019, 76 (4), pp. 459 - 460

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.